Education
About Us
Working with TipRanks
Follow Us
Qyuns Therapeutics Co., Ltd. Class H (HK:2509)
:2509
2509 Stock Chart & Stats
HK$28.58
HK$0.02(0.29%)
At close: 4:00 PM EST
HK$28.58
HK$0.02(0.29%)
Day’s Range― - ―
52-Week RangeHK$5.95 - HK$36.50
Previous CloseN/A
Volume3.00K
Average Volume (3M)766.11K
Market Cap
HK$6.61B
Enterprise ValueHK$3.45B
Total Cash (Recent Filing)HK$558.90M
Total Debt (Recent Filing)HK$635.93M
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Mar 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding227,071,600
10 Day Avg. Volume583,475
30 Day Avg. Volume766,111
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)6.64
Price to Sales (P/S)9.58
P/FCF Ratio-8.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Qyuns Therapeutics Co., Ltd. Class H News
2509 FAQ
What was Qyuns Therapeutics Co., Ltd. Class H’s price range in the past 12 months?
Qyuns Therapeutics Co., Ltd. Class H lowest stock price was HK$5.95 and its highest was HK$36.50 in the past 12 months.
What is Qyuns Therapeutics Co., Ltd. Class H’s market cap?
Qyuns Therapeutics Co., Ltd. Class H’s market cap is HK$6.61B.
When is Qyuns Therapeutics Co., Ltd. Class H’s upcoming earnings report date?
Qyuns Therapeutics Co., Ltd. Class H’s upcoming earnings report date is Mar 27, 2026 which is in 144 days.
How were Qyuns Therapeutics Co., Ltd. Class H’s earnings last quarter?
Qyuns Therapeutics Co., Ltd. Class H released its earnings results on Aug 15, 2025. The company reported -HK$0.137 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.137.
Is Qyuns Therapeutics Co., Ltd. Class H overvalued?
According to Wall Street analysts Qyuns Therapeutics Co., Ltd. Class H’s price is currently Overvalued.
Does Qyuns Therapeutics Co., Ltd. Class H pay dividends?
Qyuns Therapeutics Co., Ltd. Class H does not currently pay dividends.
What is Qyuns Therapeutics Co., Ltd. Class H’s EPS estimate?
Qyuns Therapeutics Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qyuns Therapeutics Co., Ltd. Class H have?
Qyuns Therapeutics Co., Ltd. Class H has 227,071,600 shares outstanding.
What happened to Qyuns Therapeutics Co., Ltd. Class H’s price movement after its last earnings report?
Qyuns Therapeutics Co., Ltd. Class H reported an EPS of -HK$0.137 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.248%.
Which hedge fund is a major shareholder of Qyuns Therapeutics Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2509
Qyuns Therapeutics Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
94.10%
12-Months-Change
Fundamentals
Return on Equity
-64.62%
Trailing 12-Months
Asset Growth
7.41%
Trailing 12-Months
Company Description
Qyuns Therapeutics Co., Ltd. Class H
Qyuns Therapeutics Co., Ltd. Class H (2509) is a pharmaceutical company engaged in the development, manufacturing, and commercialization of innovative therapeutic products. The company operates in the biotech sector, focusing on producing cutting-edge drugs and treatments for various medical conditions. Its core offerings include a range of proprietary medications and therapeutic solutions aimed at improving patient outcomes and addressing unmet medical needs.
Technical Analysis
TOT BIOPHARM International Co. Ltd.
―
JW (Cayman) Therapeutics Co. Ltd.
―
Clover Biopharmaceuticals Ltd.
―
Sirnaomics Ltd.
―
Transcenta Holding Limited
―